Ligand Pharmaceuticals Q1 2024 Adj EPS $3.84 Beats $0.78 Estimate, Sales $30.978M Beat $27.924M Estimate
Author: Benzinga Newsdesk | May 07, 2024 04:17pm
Ligand Pharmaceuticals (NASDAQ:
LGND) reported quarterly earnings of $3.84 per share which beat the analyst consensus estimate of $0.78 by 392.31 percent. This is a 68.42 percent increase over earnings of $2.28 per share from the same period last year. The company reported quarterly sales of $30.978 million which beat the analyst consensus estimate of $27.924 million by 10.94 percent. This is a 29.56 percent decrease over sales of $43.979 million the same period last year.
Posted In: LGND